In recent years, specific biological functions have been attributed to modifications of the oligosaccharide units of glycoconjugates, such as phosphorylation, O-acetylation and sulfation. The long term aimn of this program is to study modifications of N-linked oligosaccharides and to understand their biological roles in helath and disease. We have discovered two novel classes of sulfated N- linked oligosaccharides in mammalian cells. The first is a class of multiantennary complex-type oligosaccharides carrying Sialic acids and O-Sulfate esters (SSOs) and the second is a family of N- Linked molecules carrying Glycosaminoglycan-like chains attached to complex-type oligosaccharides (NLGs). This application proposes to study the complete structures and biosynthesis of these novel molecules, and to explore their biological roles. The complete structures will be elucidated using both labelled and unlabelled matrials, by the production of monoclonal antibodies against unique epitopes, and by the purification of specific sulfatases. particular attention will be paid to the nature of the linkage between the sulfated side chains and the core portion of the oligosaccharide. In selected cases, the nature of the proteins carrying these molecules will also be investigated. The effects of para-nitrophenyl xyloside and of selected inhibitors of processing glycosidases upon the biosynthesis of both types of molecules will be explored. The biosynthetic intermediates of these molecules will be identified by labelling either intact Golgi vesicles, cells at lowered temperature, or cells exposed to monensin. This will allow the prediction of the overall biosynthetic pathways for the initiation and synthesis of both types of chains. Based upon all of the above, selected studies of the enzymology of these pathways will be carried out. In parallel with these studies, we will examine further the structure and biosynthesis of both SSOs and NLGs that we have found on a single pancreatic tumor antigen. The unusual nature of these structures suggests that they have interesting biological roles. Labelled SSOs will be used as ligands to search for their cognate receptors in cell membranes. Preliminary studies suggest that the LGs of pulmonary vascular endothelial cells bind to Antithrombin III, and therefore, could have a role in the control of thrombogenesis in the pulmonary vasculature. We will also compare the biological roles of the NLGs with others already known for the more typical O-linked heparin/heparan sulfate proteoglycans. Other biological roles for both types of structures may be predicted by the structural, biosynthetic and receptor binding studies. in the long run, studies of these novel molecules may be of importance in such diverse processes as the control of endothelial and smooth muscle proliferation, the adhesion of tumor cells in the process of metastases, and the control of thrombogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA038701-04
Application #
3176912
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1985-08-01
Project End
1993-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Läubli, Heinz; Varki, Ajit; Borsig, Lubor (2016) Antimetastatic Properties of Low Molecular Weight Heparin. J Clin Oncol 34:2560-1
Schwarz, Flavio; Fong, Jerry J; Varki, Ajit (2015) Human-specific evolutionary changes in the biology of siglecs. Adv Exp Med Biol 842:1-16
Samraj, Annie N; Pearce, Oliver M T; Läubli, Heinz et al. (2015) A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A 112:542-7
Varki, Nissi M; Varki, Ajit (2015) On the apparent rarity of epithelial cancers in captive chimpanzees. Philos Trans R Soc Lond B Biol Sci 370:
Samraj, Annie N; Läubli, Heinz; Varki, Nissi et al. (2014) Involvement of a non-human sialic Acid in human cancer. Front Oncol 4:33
Chang, Yung-Chi; Olson, Joshua; Beasley, Federico C et al. (2014) Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLoS Pathog 10:e1003846
Pearce, Oliver Mt; Läubli, Heinz; Bui, Jack et al. (2014) Hormesis in cancer immunology: Does the quantity of an immune reactant matter? Oncoimmunology 3:e29312
Läubli, Heinz; Pearce, Oliver M T; Schwarz, Flavio et al. (2014) Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci U S A 111:14211-6
Deng, Lingquan; Song, Jeongmin; Gao, Xiang et al. (2014) Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi. Cell 159:1290-9
Pearce, Oliver M T; Läubli, Heinz; Verhagen, Andrea et al. (2014) Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A 111:5998-6003

Showing the most recent 10 out of 85 publications